Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation.

Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation.
复制标题

DOI:
10.1172/jci114505
复制
发表时间:
1990-03
期刊:
The Journal of clinical investigation
影响因子:
--
通讯作者:
M. Simonson;Michael J. Dunn
M. Simonson;Michael J. Dunn
中科院分区:
其他
文献类型:
--
作者:
M. Simonson;Michael J. Dunn

文献摘要

被引文献

相似文献

新分离的肽,内皮素-1(ET-1),是一种有效的升压剂,降低肾小球滤过率和肾小球超滤系数。最近的证据表明,ET-1通过激活磷酸肌醇级联来动员肾小球系膜细胞内的Ca ~(2+)[(Ca ~(2+)]i)。本实验旨在研究ET-1是否刺激系膜细胞收缩并调节PGE 2和cAMP的合成,从而抑制血管收缩剂诱导的系膜收缩。ET-1(大于或等于1 nM)减少了在I型胶原三维凝胶上培养的大鼠系膜细胞的横截面积。ET-1也引起复杂的重排的F-肌动蛋白微丝一致的能动性反应。收缩反应ET-1只发生在激活磷脂酶C的浓度,收缩不受二氢吡啶敏感的钙通道的封锁。离子霉素升高[Ca 2 +]i,与ET-1达到的[Ca 2 +]i浓度相当,也降低了系膜细胞横截面积。ET-1(0.1 μ M)也诱发[3 H]花生四烯酸释放和PGE 2合成增加5倍,以及PGF 2 α合成增加和TXB 2的微小变化。ET-1只在3-异丁基-1-甲基黄嘌呤的存在下引起细胞内cAMP积累的轻微增加。ET-1也增加了cAMP的产生,以响应异丙肾上腺素。TPA和离子霉素,单独和组合,未能模仿ET-1的增强作用,然而,吲哚美辛阻断ET-1诱导的增强异丙肾上腺素刺激的cAMP,这是恢复通过添加外源性10 nM PGE 2。因此,目前的数据表明,ET-1刺激肾小球系膜细胞收缩,通过药物力学耦合和激活磷脂酶A2产生PGE 2,PGF 2 α,和TXB 2。ET-1还通过PGE 2依赖性机制放大β肾上腺素能刺激的cAMP积累。
The newly isolated peptide, endothelin-1 (ET-1), is a potent pressor agent that reduces GFR and the glomerular ultrafiltration coefficient. Recent evidence demonstrates that ET-1 mobilizes intracellular Ca2+ [( Ca2+]i) in glomerular mesangial cells by activating the phosphoinositide cascade. The present experiments were designed to examine whether ET-1 stimulates mesangial cell contraction and regulates the synthesis of PGE2 and cAMP, which dampen vasoconstrictor-induced mesangial contraction. ET-1 (greater than or equal to 1 nM) reduced the cross-sectional area of rat mesangial cells cultured on three-dimensional gels of collagen type I. ET-1 also caused complex rearrangements of F-actin microfilaments consistent with a motile response. Contraction in response to ET-1 occurred only at concentrations that activate phospholipase C, and contraction was unaffected by blockade of dihydropyridine-sensitive Ca2+ channels. Elevation of [Ca2+]i with ionomycin, to equivalent concentrations of [Ca2+]i achieved with ET-1, also reduced mesangial cell cross-sectional area. ET-1 (0.1 microM) also evoked [3H]arachidonate release and a fivefold increase in PGE2 synthesis as well as increased synthesis of PGF2 alpha and small changes of TXB2. ET-1 caused a minor increase in intracellular cAMP accumulation only in the presence of 3-isobutyl-1-methylxanthine. ET-1 also amplified cAMP production in response to isoproterenol. TPA and ionomycin, alone and in combination, failed to mimic the potentiating effect of ET-1; however, indomethacin blocked ET-1-induced potentiation of isoproterenol-stimulated cAMP, which was restored by addition of exogenous 10 nM PGE2. Thus the present data demonstrate that ET-1 stimulates mesangial cell contraction via pharmacomechanical coupling and activates phospholipase A2 to produce PGE2, PGF2 alpha, and TXB2. ET-1 also amplified beta adrenergic-stimulated cAMP accumulation by a PGE2-dependent mechanism.